Figure 3.

CTC grade ≥ 3 infections in patients with or without recovery of thymopoiesis. Cumulative incidence of first CTC grade ≥3 infection in months beyond the time-points of measurement in patients with (>0) or without (0) sjTREC⁺ T-cell recovery as measured at 2 (A), 6 (B), 9 (C) and 12 (D) months after allogeneic HSCT. N: number of patients evaluated; d: number of patients reaching the endpoint. P values of likelihood ratio testing: 0.45 (2 months); 0.06 (6 months); 0.81 (9 months); and 0.01 (12 months).